Evidence map›Paper›PMID 27076519›Full record

ArticleJournal of cell science2016

Optogenetic activation reveals distinct roles of PIP3 and Akt in adipocyte insulin action.

Yingke Xu, Di Nan, Jiannan Fan, Jonathan S Bogan, Derek Toomre

Open access · greenAbstract read
In one paragraph

Article in Journal of cell science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
18.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Optogenetic control of mitochondrial aggregation and function.Frontiers in bioengineering and biotechnology · 2024
    Article
  8. Article
  9. Regulation of EGF-stimulated activation of the PI-3K/AKT pathway by exocyst-mediated exocytosis.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  10. GLUT4 On the move.The Biochemical journal · 2022
    Article
  11. Review
  12. CaJournal of cellular physiology · 2021
    Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Yingke XuDepartment of Biomedical Engineering, MOE Key Laboratory of Biomedical Engineering, Zhejiang Provincial Key Laboratory of Cardio-Cerebral Vascular Detection Technology and Medicinal Effectiveness Appraisal, Zhejiang University, Hangzhou 310027, China Department of Cell Biology, Yale University School of Medicine, New Haven, 06510, USA yingkexu@zju.edu.cn derek.toomre@yale.edu.ORCID 0000-0002-8317-0608
Di NanDepartment of Biomedical Engineering, MOE Key Laboratory of Biomedical Engineering, Zhejiang Provincial Key Laboratory of Cardio-Cerebral Vascular Detection Technology and Medicinal Effectiveness Appraisal, Zhejiang University, Hangzhou 310027, China.
Jiannan FanDepartment of Biomedical Engineering, MOE Key Laboratory of Biomedical Engineering, Zhejiang Provincial Key Laboratory of Cardio-Cerebral Vascular Detection Technology and Medicinal Effectiveness Appraisal, Zhejiang University, Hangzhou 310027, China.ORCID 0000-0002-6392-8493
Jonathan S BoganDepartment of Cell Biology, Yale University School of Medicine, New Haven, 06510, USA Section of Endocrinology and Metabolism, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520-8020, USA.ORCID 0000-0001-6463-8466
Derek ToomreDepartment of Cell Biology, Yale University School of Medicine, New Haven, 06510, USA yingkexu@zju.edu.cn derek.toomre@yale.edu.ORCID 0000-0002-6827-8127
Yale University · USZhejiang University · CN

Funding

Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI GERALD I SHULMAN · 1993 to 2026
$44.0M
Vesicle Translocation and the Metabolic SyndromeR01DK092661 · NIDDK · YALE UNIVERSITY · PI BOGAN, JONATHAN · 2012 to 2018
$2.0M
Dynamics of exocyst recruitment and assemblyR01GM098498 · NIGMS · YALE UNIVERSITY · PI TOOMRE, DEREK K. · 2013 to 2015
$1.0M
NIDDK NIH HHS P30 DK045735NIDDK NIH HHS R01 DK092661NIGMS NIH HHS R01 GM098498
6 · The paper itself

Abstract

Glucose transporter 4 (GLUT4; also known as SLC2A4) resides on intracellular vesicles in muscle and adipose cells, and translocates to the plasma membrane in response to insulin. The phosphoinositide 3-kinase (PI3K)-Akt signaling pathway plays a major role in GLUT4 translocation; however, a challenge has been to unravel the potentially distinct contributions of PI3K and Akt (of which there are three isoforms, Akt1-Akt3) to overall insulin action. Here, we describe new optogenetic tools based on CRY2 and the N-terminus of CIB1 (CIBN). We used these 'Opto' modules to activate PI3K and Akt selectively in time and space in 3T3-L1 adipocytes. We validated these tools using biochemical assays and performed live-cell kinetic analyses of IRAP-pHluorin translocation (IRAP is also known as LNPEP and acts as a surrogate marker for GLUT4 here). Strikingly, Opto-PIP3 largely mimicked the maximal effects of insulin stimulation, whereas Opto-Akt only partially triggered translocation. Conversely, drug-mediated inhibition of Akt only partially dampened the translocation response of Opto-PIP3 In spatial optogenetic studies, focal targeting of Akt to a region of the cell marked the sites where IRAP-pHluorin vesicles fused, supporting the idea that local Akt-mediated signaling regulates exocytosis. Taken together, these results indicate that PI3K and Akt play distinct roles, and that PI3K stimulates Akt-independent pathways that are important for GLUT4 translocation.

Indexed as

3T3 CellsAdipocytesAnimalsCell MembraneExocytosisGlucoseGlucose Transporter Type 4HumansInsulinMiceOptogeneticsPhosphatidylinositol 3-KinasesProtein TransportProto-Oncogene Proteins c-aktSignal TransductionAkt1 protein, mouseAkt3 protein, mouseGlucoseGlucose Transporter Type 4InsulinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSlc2a4 protein, mouseExocytosisGlucose transporterInsulin signalingOptogeneticsTIRFM

Identifiers

PMID27076519
PMCPMC4878990
OpenAlexW2339258545

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.